{"id":71466,"date":"2026-05-20T12:20:00","date_gmt":"2026-05-20T12:20:00","guid":{"rendered":"https:\/\/medsbase.com\/b12-cyanocobalamin\/"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"b12-cyanocobalamin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/b12-cyanocobalamin\/","title":{"rendered":"Vitamin B12 (Cyanocobalamin) Injectable \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 B12\uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff09\u6ce8\u5c04\u5264\u3068\u306f\uff1f<\/h3>\n<p style=\"margin: 0;\"><strong>\u30d3\u30bf\u30df\u30f3B12 (\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3)<\/strong> \u306f\u3001\u30b3\u30d0\u30e9\u30df\u30f3\u88dc\u9175\u7d20\u30d5\u30a1\u30df\u30ea\u30fc\u306e\u5408\u6210\u30b7\u30a2\u30ce\u914d\u4f4d\u578b\uff08CAS 68-19-9\u3001\u5206\u5b50\u5f0f C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P\u3001\u5206\u5b50\u91cf 1355.37 g\/mol\uff09\u3002\u5f53\u5e97\u3067\u306f\u3001 <strong>10 mg\/10 mL \u306e\u8907\u6570\u56de\u6295\u4e0e\u53ef\u80fd\u306a\u6ce8\u5c04\u7528\u30d0\u30a4\u30a2\u30eb<\/strong> (1 mg\/mL pre-formulated sterile aqueous solution \u2014 no reconstitution required) for studies and companion-protocol use alongside the peptide catalogue. Cyanocobalamin is the most-cited B12 form in published studies because it is the most chemically stable: cells take it up via the transcobalamin-II \/ cubilin pathway and convert it intracellularly to the two biologically-active cobalamin forms \u2014 <strong>\u30e1\u30c1\u30eb\u30b3\u30d0\u30e9\u30df\u30f3<\/strong> \uff08\u30e1\u30c1\u30aa\u30cb\u30f3\u5408\u6210\u9175\u7d20\/SAM\u30b5\u30a4\u30af\u30eb\/\u4e00\u70ad\u7d20\u4ee3\u8b1d\u306e\u88dc\u56e0\u5b50\uff09\u304a\u3088\u3073 <strong>\u30a2\u30c7\u30ce\u30b7\u30eb\u30b3\u30d0\u30e9\u30df\u30f3<\/strong> (cofactor for methylmalonyl-CoA mutase \/ odd-chain fatty acid metabolism \/ TCA entry). For clinical studies use only. <em>\u30da\u30d7\u30c1\u30c9\u3067\u306f\u3042\u308a\u307e\u305b\u3093<\/em> \u2014 \u5c0f\u5206\u5b50\u30b3\u30d0\u30eb\u30c8\u4e2d\u5fc3\u306e\u30b3\u30ea\u30ce\u30a4\u30c9\u88dc\u9175\u7d20\u3002<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pre-formulated sterile aqueous solution \u00b7 \u226599% HPLC-verified cyanocobalamin \u00b7 COA available on request \u00b7 Discreet temperature-controlled packaging \u00b7 Worldwide peptide courier \u00b7 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5316\u5408\u7269\u30af\u30e9\u30b9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u30b3\u30d0\u30eb\u30c8\u4e2d\u5fc3\u306e\u30b3\u30ea\u30ce\u30a4\u30c9\u88dc\u9175\u7d20\uff1b\u30d3\u30bf\u30df\u30f3B12\u30d5\u30a1\u30df\u30ea\u30fc\uff1b\u5c0f\u5206\u5b50\u88dc\u56e0\u5b50\uff1b; <em>\u30da\u30d7\u30c1\u30c9\u3067\u306f\u3042\u308a\u307e\u305b\u3093<\/em><\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5316\u5b66\u540d<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff08\u5225\u540d\uff1a\u30d3\u30bf\u30df\u30f3B12\u3001\u30b3\u30d0\u30e9\u30df\u30f3\uff08\u30b7\u30a2\u30ce\u578b\uff09\u3001CN-B12\uff1b\u30b3\u30d0\u30e9\u30df\u30f3\u30d5\u30a1\u30df\u30ea\u30fc\u306e\u5408\u6210\u30b7\u30a2\u30ce\u914d\u4f4d\u5b89\u5b9a\u5316\u578b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">68-19-9\uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff09\uff1b\u95a2\u9023\u30b3\u30d0\u30e9\u30df\u30f3CAS \u2014 \u30e1\u30c1\u30eb\u30b3\u30d0\u30e9\u30df\u30f3 13422-55-4\u3001\u30d2\u30c9\u30ed\u30ad\u30bd\u30b3\u30d0\u30e9\u30df\u30f3 13422-51-0\u3001\u30a2\u30c7\u30ce\u30b7\u30eb\u30b3\u30d0\u30e9\u30df\u30f3 13870-90-1\uff08\u5f53\u5e97\u3067\u306f\u53d6\u308a\u6271\u3044\u306a\u3057\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1355.37 g\/mol<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4f5c\u7528\u6a5f\u5e8f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u306f\u53d7\u5bb9\u4f53\u4ecb\u5728\u6027\u30c8\u30e9\u30f3\u30b9\u30b3\u30d0\u30e9\u30df\u30f3II \u2192 \u30ad\u30e5\u30d3\u30ea\u30f3\u7d4c\u8def\u3092\u4ecb\u3057\u3066\u7d30\u80de\u306b\u4fb5\u5165\u3057\u3001\u7d30\u80de\u5185\u3067\u30e1\u30c1\u30aa\u30cb\u30f3\u5408\u6210\u9175\u7d20\u9084\u5143\u9175\u7d20\uff08MTRR\uff09\u304a\u3088\u3073\u30e1\u30c1\u30eb\u30de\u30ed\u30f3\u9178\u5c3f\u75c7cblA\u578b\u30bf\u30f3\u30d1\u30af\u8cea\uff08MMAA\uff09\u306b\u3088\u308a\u30012\u3064\u306e\u751f\u7269\u5b66\u7684\u306b\u6d3b\u6027\u306a\u30b3\u30d0\u30e9\u30df\u30f3\u88dc\u9175\u7d20\u306b\u5909\u63db\u3055\u308c\u307e\u3059 \u2014 <strong>\u30e1\u30c1\u30eb\u30b3\u30d0\u30e9\u30df\u30f3<\/strong> \uff08\u30e1\u30c1\u30aa\u30cb\u30f3\u5408\u6210\u9175\u7d20\u306e\u7d30\u80de\u8cea\u88dc\u56e0\u5b50\uff09\u304a\u3088\u3073 <strong>\u30a2\u30c7\u30ce\u30b7\u30eb\u30b3\u30d0\u30e9\u30df\u30f3<\/strong> \uff08\u30e1\u30c1\u30eb\u30de\u30ed\u30cb\u30ebCoA\u30e0\u30bf\u30fc\u30bc\u306e\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u88dc\u56e0\u5b50\uff09\u3002\u4e21\u88dc\u9175\u7d20\u306f\u3001\u305d\u308c\u305e\u308c\u4e00\u70ad\u7d20\uff0f\u30e1\u30c1\u30eb\u5316\u4ee3\u8b1d\u3068\u30d7\u30ed\u30d4\u30aa\u30cb\u30ebCoA\uff0f\u5947\u6570\u9396\u8102\u80aa\u9178\u4ee3\u8b1d\u306b\u4e0d\u53ef\u6b20\u3067\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u8a72\u5f53\u306a\u3057\uff08\u4f4e\u5206\u5b50\u30b3\u30ea\u30ce\u30a4\u30c9\u88dc\u9175\u7d20 \u2014 \u30da\u30d7\u30c1\u30c9\u3067\u306f\u3042\u308a\u307e\u305b\u3093\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5264\u5f62\u304a\u3088\u3073\u6fc3\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>\u7121\u83cc\u306e\u8abf\u88fd\u6e08\u307f\u6c34\u6eb6\u6db2<\/strong> \u2014 1 mg\/mL cyanocobalamin in physiological-buffer base, 10 mL multi-dose vial (10 mg total cyanocobalamin per vial). Characteristic deep red colour from the cobalt-corrin chromophore. <strong>\u518d\u6eb6\u89e3\u306f\u4e0d\u8981\u3067\u3059<\/strong> \u2014 \u7121\u83cc\u30b7\u30ea\u30f3\u30b8\u3092\u7528\u3044\u3066\u7121\u83cc\u7684\u306b\u5206\u53d6\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u7d14\u5ea699%\u4ee5\u4e0a\uff08HPLC\u691c\u8a3c\u6e08\u307f\uff09\uff1bUSP\u898f\u683c\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u6a19\u6e96\u54c1\u3002\u8a66\u9a13\u6210\u7e3e\u66f8\uff08COA\uff09\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\u53ef\u80fd\u3067\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u6c34\u6eb6\u6027\u304c\u975e\u5e38\u306b\u9ad8\u3044\uff0825 \u00b0C\u3067\u306e\u6eb6\u89e3\u5ea6\u9650\u754c\u306f\u7d0412.5 mg\/mL\uff09\uff1b\u8abf\u88fd\u6e08\u307f\u6eb6\u6db2\u306f\u98fd\u548c\u6fc3\u5ea6\u3092\u5341\u5206\u306b\u4e0b\u56de\u3063\u3066\u3044\u307e\u3059\u3002pH 4\uff5e7\u306e\u6c34\u6027\u7de9\u885d\u6db2\u4e2d\u3067\u5b89\u5b9a\u3002\u30a2\u30eb\u30ab\u30ea\u6027\u6761\u4ef6\uff08\u6025\u901f\u306a\u30d2\u30c9\u30ed\u30ad\u30bd\u30b3\u30d0\u30e9\u30df\u30f3\u751f\u6210\uff09\u304a\u3088\u3073\u5f37\u9084\u5143\u6761\u4ef6\uff08\u30b3\u30d6(II)\u30a2\u30e9\u30df\u30f3\u751f\u6210\uff09\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">2\uff5e8 \u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3001; <strong>\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044<\/strong> \uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u306f\u5149\u611f\u53d7\u6027\u304c\u3042\u308a\u3001\u7d2b\u5916\u7dda\uff0f\u9752\u8272\u5149\u304c\u30b7\u30a2\u30ce\u57fa\u304b\u3089\u30d2\u30c9\u30ed\u30ad\u30bd\u57fa\u3078\u306e\u5909\u63db\u3092\u89e6\u5a92\u3057\u307e\u3059\uff09\u3002\u521d\u56de\u7a7f\u523a\u5f8c\u3001\u30de\u30eb\u30c1\u30c9\u30fc\u30ba\u30d0\u30a4\u30a2\u30eb\u306f60\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u3055\u305b\u306a\u3044\u3067\u304f\u3060\u3055\u3044\uff08\u6c37\u6676\u5f62\u6210\u306b\u3088\u308a\u30ac\u30e9\u30b9\u30d0\u30a4\u30a2\u30eb\u304c\u7834\u640d\u3059\u308b\u6050\u308c\u304c\u3042\u308a\u3001\u51cd\u7d50\u4fdd\u5b58\u304c\u9577\u5f15\u304f\u3068\u5149\u5206\u89e3\u52a3\u5316\u306e\u30ea\u30b9\u30af\u304c\u3042\u308a\u307e\u3059\uff09\u3002\u30d0\u30a4\u30a2\u30eb\u30e9\u30d9\u30eb\u306b\u8a18\u8f09\u3055\u308c\u305f\u4f7f\u7528\u671f\u9650\u5185\uff08\u901a\u5e38\u3001\u88fd\u9020\u304b\u308924\u304b\u6708\uff09\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u30d3\u30bf\u30df\u30f3B12\uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff09\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h2>\n<p><strong>\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3<\/strong> \uff08CAS 68-19-9\uff09\u306f\u3001\u30d3\u30bf\u30df\u30f3B12\u30d5\u30a1\u30df\u30ea\u30fc\u306b\u5c5e\u3059\u308b\u30b3\u30d0\u30e9\u30df\u30f3\u88dc\u9175\u7d20\u306e\u5408\u6210\u30b7\u30a2\u30ce\u914d\u4f4d\u578b\u3067\u3059\u3002\u69cb\u9020\u7684\u306b\u306f\u3001\u8907\u96d1\u306a\u30b3\u30d0\u30eb\u30c8\u4e2d\u5fc3\u306e\u30b3\u30ea\u30ce\u30a4\u30c9\u3067\u3042\u308a\u300119\u539f\u5b50\u306e\u5927\u74b0\u72b6\u74b0\uff08\u30d8\u30e2\u30b0\u30ed\u30d3\u30f3\u306e\u30dd\u30eb\u30d5\u30a3\u30ea\u30f3\u74b0\u3068\u5e7e\u4f55\u5b66\u7684\u306b\u985e\u4f3c\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u7d44\u6210\u304c\u7570\u306a\u308b\u30b3\u30ea\u30f3\u74b0\uff09\u304c\u4e2d\u5fc3\u306e\u30b3\u30d0\u30eb\u30c8\u30a4\u30aa\u30f3\u30923+\u306e\u9178\u5316\u72b6\u614b\u3067\u914d\u4f4d\u3057\u3001\u30b8\u30e1\u30c1\u30eb\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30fc\u30eb\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u5c3e\u90e8\u304c\u74b0\u306e\u4e0b\u65b9\u306b\u5782\u308c\u4e0b\u304c\u308a\u3001\u30b7\u30a2\u30ce\uff08-CN\uff09\u57fa\u304c\u4e0a\u90e8\u306e\u8ef8\u914d\u4f4d\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u5206\u5b50\u5f0fC<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P, molecular weight 1355.37 g\/mol. The molecule is intensely red \u2014 its visible-spectrum absorption (\u03bbmax ~360, ~520, ~550 nm) is what gives B12 solutions their characteristic deep pink-red colour. The &#8220;cyano&#8221; form is a synthetic stabilisation choice rather than a biologically-significant species in vivo. Cobalamins in cells exist primarily as <strong>\u30e1\u30c1\u30eb\u30b3\u30d0\u30e9\u30df\u30f3<\/strong> \uff08\u4e0a\u90e8\u8ef8\u4f4d\u306b\u30e1\u30c1\u30eb\u57fa\u3092\u6301\u3064\u3082\u306e \u2014 \u30e1\u30c1\u30aa\u30cb\u30f3\u5408\u6210\u9175\u7d20\u306e\u7d30\u80de\u8cea\u88dc\u56e0\u5b50\uff09\u304a\u3088\u3073 <strong>\u30a2\u30c7\u30ce\u30b7\u30eb\u30b3\u30d0\u30e9\u30df\u30f3<\/strong> (a 5\u2032-deoxyadenosyl group on the upper axial position \u2014 the mitochondrial cofactor for methylmalonyl-CoA mutase). These two active forms are interconverted by dedicated cellular enzymes and are not commercially supplied in stable injectable form because of their light-sensitivity. Cyanocobalamin is supplied instead because the cyano group is photochemically and thermally stable, and cells convert cyanocobalamin to the methyl and adenosyl forms intracellularly via methionine synthase reductase (MTRR) and the methylmalonic aciduria cblA-type protein (MMAA), respectively. In the studies and clinical context, cyanocobalamin injectable preparations are the canonical supplemental form. The 10 mL multi-dose vial format (1 mg\/mL \u00d7 10 mL = 10 mg per vial) supplied here matches the standard pharmaceutical preparation pattern. MedsBase stocks this format in the peptide-studies catalogue as a small-molecule companion compound used in protocols that combine peptide studies with cobalamin-axis biology \u2014 recovery, methylation-cycle studies, hematology, cognitive studies with nootropic peptides, and energy-metabolism panels where the SAM cycle is engaged. <\/p>\n<h2>\u4f5c\u7528\u6a5f\u5e8f \u2014 2\u3064\u306e\u30b3\u30d0\u30e9\u30df\u30f3\u88dc\u9175\u7d20\u53cd\u5fdc<\/h2>\n<p>B12\uff0f\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u306e\u751f\u7269\u5b66\u7684\u4f5c\u7528\u6a5f\u5e8f\u306f\u3001\u305d\u3053\u304b\u3089\u6d3e\u751f\u3059\u308b\u6d3b\u6027\u578b\u30b3\u30d0\u30e9\u30df\u30f3\u88dc\u9175\u7d20\u306b\u3088\u3063\u3066\u89e6\u5a92\u3055\u308c\u308b\u3001\u4ee5\u4e0b\u306e2\u3064\u306e\u9175\u7d20\u53cd\u5fdc\u306e\u7dcf\u548c\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>\u30c8\u30e9\u30f3\u30b9\u30b3\u30d0\u30e9\u30df\u30f3-II \u2192 \u30ad\u30e5\u30d3\u30ea\u30f3\uff0f\u30e1\u30ac\u30ea\u30f3\u3092\u4ecb\u3057\u305f\u7d30\u80de\u53d6\u308a\u8fbc\u307f<\/strong> \u2014 \u7d30\u80de\u5916\u6db2\u4e2d\u306e\u904a\u96e2\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u306f\u30c8\u30e9\u30f3\u30b9\u30b3\u30d0\u30e9\u30df\u30f3-II\uff08TCII\uff09\u3068\u7d50\u5408\u3057\u3001TCII-B12\u8907\u5408\u4f53\u306f\u7d30\u80de\u8868\u9762\u306e\u30ad\u30e5\u30d3\u30ea\u30f3\uff0f\u30e1\u30ac\u30ea\u30f3\u53d7\u5bb9\u4f53\u30b7\u30b9\u30c6\u30e0\u306b\u3088\u3063\u3066\u53d6\u308a\u8fbc\u307e\u308c\u307e\u3059\u3002\u30ea\u30bd\u30bd\u30fc\u30e0\u5185\u3078\u306e\u653e\u51fa\u5f8c\u3001LMBRD1\uff0fABCD4\u6392\u51fa\u8907\u5408\u4f53\u3092\u4ecb\u3057\u3066\u30b5\u30a4\u30c8\u30be\u30eb\u3078\u8f38\u9001\u3055\u308c\u307e\u3059\u3002<\/li>\n<li><strong>\u6d3b\u6027\u88dc\u9175\u7d20\u3078\u306e\u7d30\u80de\u5185\u5909\u63db<\/strong> \u2014 \u30b5\u30a4\u30c8\u30be\u30eb\u3067\u306f\u3001\u30e1\u30c1\u30aa\u30cb\u30f3\u30b7\u30f3\u30bf\u30fc\u30bc\u9084\u5143\u9175\u7d20\uff08MTRR\uff09\u304c\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u3092\u9084\u5143\u30fb\u30e1\u30c1\u30eb\u5316\u3057\u3001 <strong>\u30e1\u30c1\u30eb\u30b3\u30d0\u30e9\u30df\u30f3<\/strong> \uff08\u6d3b\u6027\u578b\u30b5\u30a4\u30c8\u30be\u30eb\u578b\uff09\u306b\u5909\u63db\u3057\u307e\u3059\u3002\u3053\u306e\u904e\u7a0b\u3067\u30b7\u30a2\u30ce\u57fa\u304c\u30b7\u30a2\u30f3\u5316\u7269\u3068\u3057\u3066\u5916\u308c\u307e\u3059\uff08\u751f\u6210\u91cf\u306f\u3054\u304f\u5fae\u91cf\u3067\u3042\u308a\u3001\u30ed\u30c0\u30cd\u30fc\u30bc\uff0f\u30c1\u30aa\u786b\u9178\u7cfb\u306b\u3088\u3063\u3066\u89e3\u6bd2\u3055\u308c\u307e\u3059\uff09\u3002\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u3067\u306f\u3001\u30e1\u30c1\u30eb\u30de\u30ed\u30f3\u9178\u5c3f\u75c7cblA\u578b\u30bf\u30f3\u30d1\u30af\u8cea\uff08MMAA\uff09\u3068\u30e1\u30c1\u30aa\u30cb\u30f3\u30b7\u30f3\u30bf\u30fc\u30bc\u9084\u5143\u9175\u7d20\u304c\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u3092 <strong>\u30a2\u30c7\u30ce\u30b7\u30eb\u30b3\u30d0\u30e9\u30df\u30f3<\/strong> \uff08\u6d3b\u6027\u578b\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u578b\uff09\u306b\u5909\u63db\u3057\u307e\u3059\u3002<\/li>\n<li><strong>\u30e1\u30c1\u30eb\u30b3\u30d0\u30e9\u30df\u30f3 \u2192 \u30e1\u30c1\u30aa\u30cb\u30f3\u30b7\u30f3\u30bf\u30fc\u30bc\uff08\u30b5\u30a4\u30c8\u30be\u30eb\u3001\u4e00\u70ad\u7d20\uff0fSAM\u56de\u8def\uff09<\/strong> \u2014 \u30e1\u30c1\u30aa\u30cb\u30f3\u30b7\u30f3\u30bf\u30fc\u30bc\u306f\u30015-\u30e1\u30c1\u30eb\u30c6\u30c8\u30e9\u30d2\u30c9\u30ed\u8449\u9178\u304b\u3089\u30db\u30e2\u30b7\u30b9\u30c6\u30a4\u30f3\u3078\u306e\u30e1\u30c1\u30eb\u57fa\u8ee2\u79fb\u3092\u89e6\u5a92\u3057\u3001\u30e1\u30c1\u30aa\u30cb\u30f3\u3068\u30c6\u30c8\u30e9\u30d2\u30c9\u30ed\u8449\u9178\u3092\u518d\u751f\u3057\u307e\u3059\u3002\u3053\u308c\u306fB12\u3001\u8449\u9178\u3001\u30e1\u30c1\u30aa\u30cb\u30f3\uff0fSAM\u56de\u8def\u3092\u3064\u306a\u3050\u91cd\u8981\u306a\u30ea\u30f3\u30af\u3067\u3059\u3002SAM\uff08S-\u30a2\u30c7\u30ce\u30b7\u30eb\u30e1\u30c1\u30aa\u30cb\u30f3\u3001\u30e1\u30c1\u30aa\u30cb\u30f3\uff0bATP\u304b\u3089\u751f\u6210\uff09\u306f\u3001DNA\u30e1\u30c1\u30eb\u5316\u3001\u30d2\u30b9\u30c8\u30f3\u30e1\u30c1\u30eb\u5316\u3001\u30ea\u30f3\u8102\u8cea\u30e1\u30c1\u30eb\u5316\u3001\u795e\u7d4c\u4f1d\u9054\u7269\u8cea\u30e1\u30c1\u30eb\u5316\uff08\u30ab\u30c6\u30b3\u30fc\u30eb\u30a2\u30df\u30f3\u3001\u30e1\u30e9\u30c8\u30cb\u30f3\uff09\u3001\u30af\u30ec\u30a2\u30c1\u30f3\u751f\u5408\u6210\u306a\u3069\u3001\u6570\u767e\u306b\u53ca\u3076\u7d30\u80de\u30e1\u30c1\u30eb\u5316\u53cd\u5fdc\u306e\u666e\u904d\u7684\u306a\u30e1\u30c1\u30eb\u4f9b\u4e0e\u4f53\u3067\u3059\u3002\u3057\u305f\u304c\u3063\u3066\u3001B12\u6b20\u4e4f\u306f\u7d30\u80de\u306e\u30e1\u30c1\u30eb\u5316\u30d7\u30ed\u30b0\u30e9\u30e0\u5168\u4f53\u3092\u7834\u7dbb\u3055\u305b\u3001\u3053\u308c\u304c\u81e8\u5e8a\u7684B12\u6b20\u4e4f\u75c7\u306b\u304a\u3051\u308b\u8840\u6db2\u5b66\u7684\u5f8c\u907a\u75c7\uff08DNA\u30e1\u30c1\u30eb\u5316\u4f9d\u5b58\u6027\u30c1\u30df\u30b8\u30f3\u5408\u6210\u969c\u5bb3\u306b\u3088\u308b\u5de8\u8d64\u82bd\u7403\u6027\u8ca7\u8840\uff09\u304a\u3088\u3073\u795e\u7d4c\u5b66\u7684\u5f8c\u907a\u75c7\uff08\u30ea\u30f3\u8102\u8cea\u30e1\u30c1\u30eb\u5316\u969c\u5bb3\u306b\u3088\u308b\u8131\u9ac4\uff09\u306e\u5206\u5b50\u57fa\u76e4\u3068\u306a\u308a\u307e\u3059\u3002<\/li>\n<li><strong>\u30a2\u30c7\u30ce\u30b7\u30eb\u30b3\u30d0\u30e9\u30df\u30f3 \u2192 \u30e1\u30c1\u30eb\u30de\u30ed\u30cb\u30ebCoA\u30e0\u30bf\u30fc\u30bc\uff08\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u3001\u30d7\u30ed\u30d4\u30aa\u30cb\u30ebCoA\uff0fTCA\u56de\u8def\u3078\u306e\u5165\u53e3\uff09<\/strong> \u2014 \u30e1\u30c1\u30eb\u30de\u30ed\u30cb\u30ebCoA\u30e0\u30bf\u30fc\u30bc\u306f\u3001(R)-\u30e1\u30c1\u30eb\u30de\u30ed\u30cb\u30ebCoA\u304b\u3089\u30b9\u30af\u30b7\u30cb\u30ebCoA\u3078\u306e\u5206\u5b50\u5185\u8ee2\u4f4d\u3092\u89e6\u5a92\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u5947\u6570\u9396\u8102\u80aa\u9178\u3001\u5206\u5c90\u9396\u30a2\u30df\u30ce\u9178\uff08\u30d0\u30ea\u30f3\u3001\u30a4\u30bd\u30ed\u30a4\u30b7\u30f3\u3001\u30e1\u30c1\u30aa\u30cb\u30f3\uff09\u3001\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u5074\u9396\u306a\u3069\u3001\u30d7\u30ed\u30d4\u30aa\u30cb\u30ebCoA\u751f\u6210\u57fa\u8cea\u306e\u4ee3\u8b1d\u5165\u53e3\u70b9\u3067\u3059\u3002\u30a2\u30c7\u30ce\u30b7\u30eb\u30b3\u30d0\u30e9\u30df\u30f3\u6b20\u4e4f\u306f\u30e1\u30c1\u30eb\u30de\u30ed\u30f3\u9178\u306e\u84c4\u7a4d\uff08\u81e8\u5e8a\u7684B12\u6b20\u4e4f\u306e\u8a3a\u65ad\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\uff09\u3092\u5f15\u304d\u8d77\u3053\u3057\u3001\u30d7\u30ed\u30d4\u30aa\u30cb\u30ebCoA\uff0f\u5947\u6570\u9396\u8102\u80aa\u9178\u306e\u9178\u5316\u3092\u969c\u5bb3\u3057\u307e\u3059\u3002<\/li>\n<li><strong>NAD\u8ef8\u304a\u3088\u3073\u4e00\u70ad\u7d20\u4ee3\u8b1d\u30af\u30ed\u30b9\u30c8\u30fc\u30af\u3068\u306e\u95a2\u9023<\/strong> \u2014 B12\uff0f\u30e1\u30c1\u30aa\u30cb\u30f3\u30b7\u30f3\u30bf\u30fc\u30bc\u53cd\u5fdc\u306f\u3001NNMT\uff08\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9N-\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff09\u3092\u542b\u3080\u6570\u767e\u306e\u7d30\u80de\u30e1\u30c1\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\u304c\u89e6\u5a92\u3059\u308bSAM\u6d88\u8cbb\u6027\u30e1\u30c1\u30eb\u5316\u53cd\u5fdc\u3068\u540c\u3058\u4ee3\u8b1d\u30ce\u30fc\u30c9\u306b\u4f4d\u7f6e\u3057\u3066\u304a\u308a\u3001NNMT\u306f <a href=\"https:\/\/medsbase.com\/ja\/5-amino-1mq\/\">5-Amino-1MQ<\/a>. NNMT consumes SAM to methylate nicotinamide; impaired B12 \/ methionine-synthase function lowers cellular SAM availability and therefore lowers NNMT activity indirectly. Studies that probes the NAD-axis \/ one-carbon-metabolism crossover often co-administers B12 and NNMT-pathway tools to dissect these connected biochemistries.<\/li>\n<\/ul>\n<p>The pharmacokinetic profile of injectable cyanocobalamin is well-characterised: IM or SC administration produces rapid systemic absorption with peak plasma concentrations at 1\u20132 hours; substantial dose-dependent renal clearance (the kidney saturates and dose-dumps any cyanocobalamin above the transcobalamin-II carrier capacity); cellular uptake then proceeds over hours-to-days; conversion to active coenzymes happens continuously thereafter; and the very low daily turnover requirement of cobalamin coenzymes (~2 \u00b5g\/d in human physiology) means that single high-dose injections produce sustained tissue-level effects for weeks. The 1 mg\/mL \u00d7 10 mL multi-dose format supports typical protocols ranging from single-bolus high-dose work to weekly or daily smaller-dose chronic dosing. <\/p>\n<h2>Published Evidence<\/h2>\n<p>B12 \/ cyanocobalamin is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>One-carbon metabolism and SAM-cycle studies<\/strong> \u2014 the canonical small-molecule cofactor for methionine synthase; standard tool compound for any studies that probes the folate \/ B12 \/ methionine \/ SAM axis; widely used in DNA-methylation and histone-methylation pharmacology studies<\/li>\n<li><strong>Homocysteine-axis studies<\/strong> \u2014 methionine synthase deficiency \/ impairment causes homocysteine accumulation; cyanocobalamin supplementation is the standard intervention in published studies models of hyperhomocysteinaemia and cardiovascular risk<\/li>\n<li><strong>Haematology and erythropoiesis studies<\/strong> \u2014 B12 deficiency causes megaloblastic anaemia via impaired DNA-methylation-dependent thymidine synthesis; published studies uses cyanocobalamin in vitamin-deficiency erythropoiesis models, bone-marrow culture studies, and reticulocyte-response studies<\/li>\n<li><strong>Peripheral neuropathy and demyelination studies<\/strong> \u2014 B12 deficiency causes peripheral neuropathy and subacute combined degeneration of the spinal cord via impaired phospholipid methylation in myelin sheaths; published studies uses cyanocobalamin supplementation in demyelination \/ remyelination model systems<\/li>\n<li><strong>NAD-axis \/ methylation crossover studies<\/strong> \u2014 \u4f75\u7528\u3057\u3066 <a href=\"https:\/\/medsbase.com\/ja\/5-amino-1mq\/\">5-Amino-1MQ<\/a> \uff08NNMT\u963b\u5bb3\u5264\uff09\u307e\u305f\u306f <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD\u207a<\/a> in published studies that probes the SAM-cycle \/ nicotinamide-methylation node<\/li>\n<li><strong>Recovery and athletic-applications (combined with peptide protocols)<\/strong> \u2014 frequently included as a companion compound in protocols that combine peptide therapeutics (BPC-157, TB-500, GH peptides) with cofactor \/ vitamin support; the canonical small-molecule companion to peptide-axis recovery<\/li>\n<li><strong>Cognitive and nootropic-applications<\/strong> \u2014\u8a8d\u77e5\u6a5f\u80fd\u30da\u30d7\u30c1\u30c9\u3068\u7d44\u307f\u5408\u308f\u305b\u3066\uff08<a href=\"https:\/\/medsbase.com\/ja\/selank\/\">Selank<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/semax\/\">Semax<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/dsip\/\">DSIP<\/a>) in studies on the cognitive sequelae of B12 deficiency and the cobalamin axis in CNS function<\/li>\n<li><strong>Cyanocobalamin vs methylcobalamin vs hydroxocobalamin comparative studies<\/strong> \u2014 published studies has compared the four cobalamin forms head-to-head for bioavailability, intracellular conversion kinetics, and tissue-retention profiles; cyanocobalamin is the canonical reference compound against which the others are benchmarked<\/li>\n<\/ul>\n<p>For broader context on small-molecule cofactor \/ coenzyme compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/ja\/l-carnitine\/\">L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/a> (the closest small-molecule companion analogue \u2014 mitochondrial long-chain fatty-acid shuttle), <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD\u207a<\/a> \uff08\u9178\u5316\u578b\u30b8\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u88dc\u9175\u7d20 \u2014 \u76f4\u63a5\u7684\u306aNAD\u30d7\u30fc\u30eb\u88dc\u5145\uff09\u3001, <a href=\"https:\/\/medsbase.com\/ja\/5-amino-1mq\/\">5-Amino-1MQ<\/a> \uff08NNMT\u963b\u5bb3\u5264 \u2014 B12\/\u30e1\u30c1\u30aa\u30cb\u30f3\u30b5\u30a4\u30af\u30eb\u3092NAD\u8ef8\u306b\u7d50\u3073\u3064\u3051\u308b\uff09\u3001\u304a\u3088\u3073 <a href=\"https:\/\/medsbase.com\/ja\/mots-c\/\">MOTS-c<\/a> \uff08\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u7531\u6765\u4ee3\u8b1d\u30da\u30d7\u30c1\u30c9\uff09\u3002\u5168\u30e9\u30a4\u30f3\u30ca\u30c3\u30d7\u3092\u898b\u308b <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">peptides &amp; compounds catalog<\/a>. <\/p>\n<h2>\u30d1\u30c3\u30af\u30b5\u30a4\u30ba\u4e00\u89a7<\/h2>\n<p>MedsBase\u3067\u306f\u3001\u30d3\u30bf\u30df\u30f3B12\uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff09\u6ce8\u5c04\u5264\u3092\u3001\u5358\u4e00\u6fc3\u5ea6\/\u30d0\u30a4\u30a2\u30eb\u5f62\u5f0f\u3067\u30013\u3064\u306e\u30d1\u30c3\u30af\u30b5\u30a4\u30ba\u30aa\u30d7\u30b7\u30e7\u30f3\u3092\u3054\u7528\u610f\u3057\u3066\u304a\u308a\u307e\u3059\uff1a<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Total Material<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1\u30d0\u30a4\u30a2\u30eb<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Single-experiment, dose-titration, or short-course in-vivo studies \u2014 10 mg total cyanocobalamin in 10 mL multi-dose format covers 4\u20138 weeks of typical protocol dosing in rodents or small-cohort cell-culture work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 mg \/ 10 mL<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u30d0\u30a4\u30a2\u30eb<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Multi-cohort or extended-cycle studies \u2014 typical mid-scale protocols using B12 as a companion compound alongside peptide-dosing; per-vial economics improve significantly vs single-vial purchase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50 mg \/ 50 mL<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u30d0\u30a4\u30a2\u30eb<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Large-cohort or long-arm protocols \u2014 chronic-dosing companion supply alongside long-cycle peptide protocols; lowest per-mg cost; covers multi-animal cohort work without re-purchase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100 mg \/ 100 mL<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The single 1-vial pack is convenient for single-experiment or titration work; the 5-vial and 10-vial packs provide significant per-vial savings for chronic protocols or multi-cohort studies. The 1 mg\/mL \u00d7 10 mL multi-dose format matches the standard pharmaceutical injectable cyanocobalamin pattern and is well-suited to typical protocol dosing \u2014 IM, SC, or IV administration of 100 \u00b5g to 1 mg per dose (equivalent to 0.1\u20131 mL of the supplied solution) covers essentially all published studies dose ranges. <\/p>\n<h2>\u6bd4\u8f03\uff1aB12\uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff09\u3068L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/h2>\n<p>B12\u3068 <a href=\"https:\/\/medsbase.com\/ja\/l-carnitine\/\">L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/a> are the two best-characterised small-molecule companion compounds in this catalogue. Both serve as cofactor \/ shuttle compounds in mitochondrial and metabolic support, both are supplied in multi-dose injectable formats appropriate for protocol use alongside the peptide catalogue, and both are mechanistically distinct from the peptide compounds. The comparison illustrates the two canonical &#8220;small-molecule companion&#8221; compounds that users add to peptide protocols. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">B12\uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff09<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5316\u5b66\u5206\u985e<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30b3\u30d0\u30eb\u30c8\u4e2d\u5fc3\u306e\u30b3\u30ea\u30ce\u30a4\u30c9\u88dc\u9175\u7d20\uff08\u5358\u4e00\u4f4e\u5206\u5b50\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u56db\u7d1a\u30a2\u30f3\u30e2\u30cb\u30a6\u30e0\u30a2\u30df\u30ce\u9178\u8a98\u5c0e\u4f53\uff08\u5358\u4e00\u306e\u53cc\u6027\u30a4\u30aa\u30f3\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1355.37 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">161.20 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u7d30\u80de\u306b\u304a\u3051\u308b\u5f79\u5272<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u88dc\u56e0\u5b50 \u2014 \u30e1\u30c1\u30aa\u30cb\u30f3\u5408\u6210\u9175\u7d20\uff08\u7d30\u80de\u8cea\uff0cSAM\u56de\u8def\uff09\uff0b\u30e1\u30c1\u30eb\u30de\u30ed\u30cb\u30ebCoA\u30e0\u30bf\u30fc\u30bc\uff08\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\uff0c\u30d7\u30ed\u30d4\u30aa\u30cb\u30ebCoA \u2192 TCA\u56de\u8def\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u57fa\u8cea\u8f38\u9001\u4f53 \u2014 \u9577\u9396\u8102\u80aa\u9178\u306e\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u5185\u819c\u901a\u904e\u30b7\u30e3\u30c8\u30eb\uff08\u03b2\u9178\u5316\u306e\u5165\u53e3\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">One-carbon \/ methylation, homocysteine axis, megaloblastic erythropoiesis, demyelination studies, cognitive \/ nootropic crossover<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fat oxidation, mitochondrial bioenergetics, insulin sensitivity, sperm motility, cardiovascular metabolic support<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>FDA\u627f\u8a8d<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u306f\u3044 \u2014 \u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u6ce8\u5c04\u5264\u306f\u30d3\u30bf\u30df\u30f3B12\u6b20\u4e4f\u75c7\u306b\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30d2\u30c9\u30ed\u30ad\u30bd\u30b3\u30d0\u30e9\u30df\u30f3\u306fCyanokit\uff08\u30b7\u30a2\u30ce\u30ad\u30c3\u30c8\u3001\u30b7\u30a2\u30f3\u5316\u7269\u89e3\u6bd2\u5264\uff09\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u306f\u3044 \u2014 \u30ec\u30dc\u30ab\u30eb\u30cb\u30c1\u30f3\u306f\u539f\u767a\u6027\/\u7d9a\u767a\u6027\u30ab\u30eb\u30cb\u30c1\u30f3\u6b20\u4e4f\u75c7\uff08\u7d4c\u53e3\u304a\u3088\u3073\u9759\u6ce8\uff09\u306b\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1\u65e5\u3042\u305f\u308a\u306e\u4ee3\u8b1d\u56de\u8ee2\u5fc5\u8981\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u975e\u5e38\u306b\u4f4e\u304f\uff08\u30d2\u30c8\u306e\u751f\u7406\u7684\u72b6\u6cc1\u3067\u306f\u7d042 \u00b5g\/\u65e5\uff09\u3001\u5358\u56de\u9ad8\u7528\u91cf\u6ce8\u5c04\u306b\u3088\u308a\u7d44\u7e54\u5185\u6fc3\u5ea6\u304c\u6570\u9031\u9593\u6301\u7d9a\u3057\u307e\u3059\u3002<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u9ad8\u304f\u3001\u5185\u56e0\u6027\u30ab\u30eb\u30cb\u30c1\u30f3\u30d7\u30fc\u30eb\u306f\u7d0425 g\u3067\u3042\u308a\u3001\u6b20\u4e4f\u72b6\u614b\u3067\u306e1\u65e5\u3042\u305f\u308a\u306e\u88dc\u5145\u5fc5\u8981\u91cf\u306f\u76f8\u5f53\u91cf\u3067\u3059\u3002<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4f9b\u7d66\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30d7\u30ec\u30d5\u30a9\u30fc\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u6e08\u307f\u7121\u83cc\u6c34\u6eb6\u6db2\uff081 mg\/mL \u00d7 10 mL \u30de\u30eb\u30c1\u30c9\u30fc\u30ba\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\uff08BAC\u6c34\u3067\u6eb6\u89e3\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e00\u822c\u7684\u306a\u7528\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u56de\u3042\u305f\u308a100 \u00b5g\uff5e1 mg\uff08\u4f9b\u7d66\u6eb6\u6db20.1\uff5e1 mL\uff09\u3001IM \/ SC \/ IV<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6570\u767e mg\uff5e\u30b0\u30e9\u30e0\u5358\u4f4d\/\u56de\uff08\u3052\u3063\u6b6f\u985e\uff0f\u5927\u578b\u52d5\u7269\u30d7\u30ed\u30c8\u30b3\u30eb\uff09<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on one-carbon metabolism, SAM cycle, homocysteine axis, or megaloblastic erythropoiesis, B12 \/ cyanocobalamin is the canonical small-molecule companion. For studies focused on long-chain fatty-acid oxidation, mitochondrial bioenergetics, or insulin sensitivity, <a href=\"https:\/\/medsbase.com\/ja\/l-carnitine\/\">L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/a> is the more targeted tool. The two compounds are commonly co-administered as part of broader peptide-protocols that benefit from both methylation-cycle and fatty-acid-oxidation cofactor support. <\/p>\n<h2>\u4fdd\u7ba1\u3068\u53d6\u6271\u3044<\/h2>\n<p><strong>\u4e8b\u524d\u8abf\u88fd\u6e08\u307f\u6eb6\u6db2 \u2014 \u518d\u69cb\u6210\u4e0d\u8981\u3002<\/strong> \u672c\u30ab\u30bf\u30ed\u30b0\u306e\u51cd\u7d50\u4e7e\u71e5\u30da\u30d7\u30c1\u30c9\u88fd\u54c1\u3068\u306f\u7570\u306a\u308a\u3001\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u6ce8\u5c04\u6db2\u306f\u3059\u3050\u306b\u4f7f\u7528\u3067\u304d\u308b\u7121\u83cc\u6c34\u6027\u6eb6\u6db2\u3068\u3057\u3066\u4f9b\u7d66\u3055\u308c\u307e\u3059\u3002\u6bce\u56de\u306e\u4f7f\u7528\u6642\u306b\u6ec5\u83cc\u30b7\u30ea\u30f3\u30b8\u3067\u7121\u83cc\u7684\u306b\u629c\u304d\u53d6\u3063\u3066\u304f\u3060\u3055\u3044\u3002\u30de\u30eb\u30c1\u30c9\u30fc\u30ba\u30d0\u30a4\u30a2\u30eb\u306b\u6c5a\u67d3\u7269\u8cea\u3092\u6df7\u5165\u3055\u305b\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <strong>\u4fdd\u7ba1\u65b9\u6cd5\uff1a<\/strong> \u5143\u306e\u5305\u88c5\u306e\u307e\u307e2\uff5e8 \u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u5e38\u306b\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044<\/strong> \u2014 cyanocobalamin is photosensitive (UV and short-wavelength visible light catalyses cyano-to-hydroxo and cyano-to-cob(II)alamin photoproducts). Store the vial in its original light-protective box or wrap in foil if removed. Avoid prolonged exposure to clinical ambient light during handling. <strong>Do not freeze.<\/strong> \u6c37\u6676\u306e\u5f62\u6210\u306f\u30ac\u30e9\u30b9\u30d0\u30a4\u30a2\u30eb\u3092\u7834\u640d\u3055\u305b\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u3001\u65e2\u306b\u8abf\u88fd\u6e08\u307f\u306e\u6c34\u6027\u6eb6\u6db2\u306b\u3068\u3063\u3066\u3001\u51b7\u51cd\u4fdd\u5b58\u306f\u51b7\u8535\u4fdd\u5b58\u3092\u4e0a\u56de\u308b\u5b89\u5b9a\u6027\u4e0a\u306e\u5229\u70b9\u3092\u3082\u305f\u3089\u3057\u307e\u305b\u3093\u3002\u6eb6\u6db2\u306f\u672a\u958b\u5c01\u306e\u72b6\u614b\u3067\u3001\u88fd\u9020\u65e5\u304b\u3089\u5c11\u306a\u304f\u3068\u308224\u30f6\u6708\u9593\u30012\uff5e8 \u00b0C\u3067\u5b89\u5b9a\u3067\u3059\u3002 <strong>\u521d\u56de\u7a7f\u523a\u5f8c\uff1a<\/strong> \u30de\u30eb\u30c1\u30c9\u30fc\u30ba\u30d0\u30a4\u30a2\u30eb\u306f60\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u4e8b\u524d\u8abf\u88fd\u3055\u308c\u305f\u7de9\u885d\u6db2\u306b\u306f\u3001\u30de\u30eb\u30c1\u30c9\u30fc\u30ba\u4f7f\u7528\u4e2d\u306e\u7121\u83cc\u6027\u3092\u7dad\u6301\u3059\u308b\u4fdd\u5b58\u5264\uff08\u901a\u5e38\u3001\u533b\u85ac\u54c1\u30b0\u30ec\u30fc\u30c9\u6fc3\u5ea6\u306e\u30d9\u30f3\u30b8\u30eb\u30a2\u30eb\u30b3\u30fc\u30eb\u307e\u305f\u306f\u30d5\u30a7\u30ce\u30fc\u30eb\uff09\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u30bb\u30d7\u30bf\u30e0\u3078\u306e\u7d2f\u7a4d\u7684\u306a\u7a7f\u523a\u306f\u6700\u7d42\u7684\u306b\u5fae\u751f\u7269\u4fb5\u5165\u306e\u30ea\u30b9\u30af\u3092\u3082\u305f\u3089\u3057\u307e\u3059\u3002\u6fc1\u308a\u3001\u7c92\u5b50\u72b6\u7269\u8cea\u3001\u9855\u8457\u306a\u8272\u306e\u5909\u5316\uff08\u7279\u306b\u7279\u5fb4\u7684\u306a\u6df1\u7d05\u8272\u304b\u3089\u306e\u9000\u8272 \u2014 \u5149\u5206\u89e3\u3092\u793a\u3057\u307e\u3059\uff09\u3001\u307e\u305f\u306f\u6c88\u6bbf\u304c\u73fe\u308c\u305f\u5834\u5408\u306f\u5ec3\u68c4\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h2>\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>\u4f9b\u7d66\u3055\u308c\u308bB12\u6eb6\u6db2\u304c\u6df1\u7d05\u8272\u3092\u3057\u3066\u3044\u308b\u306e\u306f\u306a\u305c\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u30b3\u30d0\u30e9\u30df\u30f3\u306e\u30b3\u30d0\u30eb\u30c8\u4e2d\u5fc3\u30b3\u30ea\u30f3\u74b0\u306f\u5f37\u529b\u306a\u53ef\u8996\u30b9\u30da\u30af\u30c8\u30eb\u767a\u8272\u56e3\u3067\u3059 \u2014 \u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u306e\u03bbmax\u5438\u53ce\u5e2f\u306f\u7d04360 nm\uff08UV\uff09\u3001\u7d04520 nm\uff08\u7dd1\u8272\uff09\u3001\u7d04550 nm\uff08\u7dd1\u9ec4\u8272\uff09\u306b\u3042\u308a\u3001\u7279\u5fb4\u7684\u306a\u30d4\u30f3\u30af\u304c\u304b\u3063\u305f\u8d64\u8272\u306e\u900f\u904e\u8272\u3092\u751f\u307f\u51fa\u3057\u307e\u3059\u3002\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u6eb6\u6db2\u306f\u3069\u308c\u3082\u6fc3\u3044\u8d64\u8272\u306b\u898b\u3048\u308b\u306f\u305a\u3067\u3059\u3002\u9ec4\u8272\u307e\u305f\u306f\u8336\u8272\u3078\u306e\u9000\u8272\u306f\u5149\u5206\u89e3\uff08\u30b7\u30a2\u30ce\u4f53\u304b\u3089\u30d2\u30c9\u30ed\u30ad\u30bd\u4f53\u3078\u306e\u5909\u63db\u3001\u307e\u305f\u306f\u30b3\u30d6(II)\u30a2\u30e9\u30df\u30f3\u3078\u306e\u3055\u3089\u306a\u308b\u9084\u5143\uff09\u3092\u793a\u3057\u3066\u304a\u308a\u3001\u30d0\u30a4\u30a2\u30eb\u306f\u5ec3\u68c4\u3059\u3079\u304d\u3067\u3059\u3002 <\/p>\n<h3>\u3053\u306eB12\u88fd\u54c1\u304c\u30e1\u30c1\u30eb\u30b3\u30d0\u30e9\u30df\u30f3\u3084\u30d2\u30c9\u30ed\u30ad\u30bd\u30b3\u30d0\u30e9\u30df\u30f3\u3067\u306f\u306a\u304f\u30b7\u30a2\u30ce\u4f53\u3092\u4f7f\u7528\u3057\u3066\u3044\u308b\u306e\u306f\u306a\u305c\u3067\u3059\u304b\uff1f<\/h3>\n<p>Cyanocobalamin is the standard form supplied as injectable B12 because it is photochemically and thermally the most stable of the cobalamin forms \u2014 the cyano group resists the photolytic degradation that affects methyl-, hydroxo-, and adenosylcobalamin in solution. Once cyanocobalamin enters cells, intracellular enzymes (MTRR, MMAA) convert it to the biologically-active methylcobalamin and adenosylcobalamin forms. For most applications, cyanocobalamin is therefore the practical choice. Users specifically studying methylcobalamin or hydroxocobalamin pharmacology (e.g., differential cellular-uptake kinetics, light-degradation pathways, or cyanide-antidote applications) require those specific forms separately. <\/p>\n<h3>\u3053\u306eB12\u88fd\u54c1\u306f\u30da\u30d7\u30c1\u30c9\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u3044\u3044\u3048\u3002\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u306f\u3001\u30b3\u30d0\u30eb\u30c8\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u5c0f\u5206\u5b50\u30b3\u30ea\u30ce\u30a4\u30c9\u88dc\u9175\u7d20\uff08\u5206\u5b50\u91cf1355.37 g\/mol\uff09\u3067\u3042\u308a\u3001, <em>\u3057\u307e\u305b\u3093<\/em> a peptide. We stock it in our peptide-studies catalogue as the canonical small-molecule companion compound used in protocols that combine peptide studies with cobalamin-axis biology. The spec table Sequence row is marked &#8220;n\/a&#8221; for this reason. Other small-molecule companions in this catalogue include <a href=\"https:\/\/medsbase.com\/ja\/l-carnitine\/\">L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD\u207a<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/5-amino-1mq\/\">5-Amino-1MQ<\/a>, Rosu HDL <a href=\"https:\/\/medsbase.com\/ja\/aicar-acadesine\/\">AICAR<\/a>. <\/p>\n<h3>What published dose ranges have been used in studies?<\/h3>\n<p>Injectable cyanocobalamin published dosing in human-clinical and rodent in-vivo work typically uses 100\u20131000 \u00b5g per dose (0.1\u20131.0 mL of the supplied 1 mg\/mL solution), IM or SC, daily for the first week and then weekly or monthly thereafter for chronic protocols. The 1000 \u00b5g single bolus is the canonical &#8220;loading dose&#8221; in clinical-translational studies. In-vitro cell-culture protocols typically use nanomolar to micromolar concentrations. Users should consult primary literature appropriate to the specific application (haematology, neuropathy, cardiovascular, one-carbon metabolism, etc.). <\/p>\n<h3>Can B12 be combined with peptides like Selank, Semax, or DSIP in protocols?<\/h3>\n<p>\u306f\u3044 \u2014 B12\u306f\u5411\u77e5\u6027\u30da\u30d7\u30c1\u30c9\uff08<a href=\"https:\/\/medsbase.com\/ja\/selank\/\">Selank<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/semax\/\">Semax<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/dsip\/\">DSIP<\/a>) in studies on the cognitive sequelae of cobalamin deficiency and the broader cobalamin-axis contribution to CNS function. B12 is also commonly co-administered with recovery peptides (BPC-157, TB-500), growth-hormone peptides (<a href=\"https:\/\/medsbase.com\/ja\/sermorelin\/\">Sermorelin<\/a>, <a href=\"https:\/\/medsbase.com\/ja\/tesamorelin\/\">Tesamorelin<\/a>\uff09\u3001\u4ee3\u8b1d\u30da\u30d7\u30c1\u30c9\uff08<a href=\"https:\/\/medsbase.com\/ja\/mots-c\/\">MOTS-c<\/a>\uff09\u3068\u306e\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u88dc\u56e0\u5b50\u3068\u3057\u3066\u3082\u4e00\u822c\u7684\u3067\u3059\u3002\u3042\u3089\u304b\u3058\u3081\u8abf\u88fd\u3055\u308c\u305f\u6c34\u6027\u88fd\u5264\u3067\u3042\u308b\u305f\u3081\u3001\u5404\u6295\u4e0e\u3054\u3068\u306b\u6e05\u6f54\u306a\u5225\u306e\u30b7\u30ea\u30f3\u30b8\u306b\u5438\u5f15\u3067\u304d\u307e\u3059\u3002\u30b3\u30d0\u30eb\u30c8-\u30b3\u30ea\u30f3\u767a\u8272\u56e3\u304c\u30c1\u30aa\u30fc\u30eb\u57fa\u3092\u542b\u3080\u30da\u30d7\u30c1\u30c9\u3068\u76f8\u4e92\u4f5c\u7528\u3057\u3066\u8efd\u5fae\u306a\u5149\u9178\u5316\u9084\u5143\u52b9\u679c\u3092\u5f15\u304d\u8d77\u3053\u3059\u53ef\u80fd\u6027\u304c\u3042\u308b\u305f\u3081\u3001\u540c\u3058\u30b7\u30ea\u30f3\u30b8\u5185\u3067\u4ed6\u306e\u30da\u30d7\u30c1\u30c9\u6eb6\u6db2\u3068\u6df7\u5408\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u304c\u6642\u3005\u30b7\u30a2\u30f3\u5316\u7269\u3068\u5171\u306b\u8a00\u53ca\u3055\u308c\u308b\u306e\u306f\u306a\u305c\u3067\u3059\u304b\uff1f<\/h3>\n<p>The cyano group on cyanocobalamin is a very small amount of bound cyanide \u2014 when intracellular enzymes convert cyanocobalamin to the active methyl\/adenosyl forms, free cyanide is released in stoichiometric amount, but the quantity is very small (~25 \u00b5g of cyanide per 1 mg of cyanocobalamin) and is detoxified by the cellular rhodanese \/ thiosulfate system without clinical significance. The opposite reaction \u2014 cobalamin scavenging cyanide \u2014 is the basis of hydroxocobalamin&#8217;s approved use as a cyanide-antidote drug (Cyanokit), where high-dose hydroxocobalamin sequesters circulating cyanide as cyanocobalamin for renal excretion. Users in cyanide-antidote studies require hydroxocobalamin specifically, not cyanocobalamin. <\/p>\n<h3>How does this pharmaceutical-grade B12 compare with the existing branded B12 products on MedsBase?<\/h3>\n<p>MedsBase\u306b\u3042\u308b\u65e2\u5b58\u306e\u30d6\u30e9\u30f3\u30c9B12\u88fd\u54c1\uff08\u4f8b\uff1a, <a href=\"https:\/\/medsbase.com\/ja\/vitamin-b12\/\">Vitamin B12 1500 mcg Tablets<\/a>) are clinical-pharmaceutical-grade B12 packaged in tablet form for oral \/ sublingual use, positioned in the nerve-health \/ energy-supplement category. The pharmaceutical-grade B12 supplied here is the injectable cyanocobalamin form in 10 mL multi-dose vial format, positioned in the peptide-studies catalogue as a small-molecule companion alongside the peptide compounds. Users requiring an oral \/ sublingual B12 supplement should use the tablet products; users requiring injectable cyanocobalamin for in-vivo or cell-culture work alongside peptide protocols can use the material supplied here. <\/p>\n<h3>B12\u306fWADA\u7981\u6b62\u30ea\u30b9\u30c8\u306b\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u3044\u3044\u3048\u3002\u30d3\u30bf\u30df\u30f3B12\uff0f\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u306fWADA\u7981\u6b62\u30ea\u30b9\u30c8\u306b\u542b\u307e\u308c\u3066\u3044\u307e\u305b\u3093\u3002\u3053\u308c\u306f\u30d3\u30bf\u30df\u30f3\uff0f\u88dc\u56e0\u5b50\u5316\u5408\u7269\u3067\u3042\u308a\u3001\u81e8\u5e8a\u7684\uff08B12\u6b20\u4e4f\u75c7\u306e\u6cbb\u7642\uff09\u306b\u3082\u3001\u30a2\u30b9\u30ea\u30fc\u30c8\u306e\u6587\u8108\u3067\u8a31\u53ef\u3055\u308c\u305f\u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\u3068\u3057\u3066\u3082\u4e00\u822c\u7684\u306b\u4f7f\u7528\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u3084\u4ed6\u306e\u30b3\u30d0\u30e9\u30df\u30f3\u5f62\u614b\u306b\u5bfe\u3057\u3066\u3001\u904b\u52d5\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u306b\u95a2\u3059\u308b\u898f\u5236\u4e0a\u306e\u5236\u9650\u306f\u3042\u308a\u307e\u305b\u3093\u3002 <\/p>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 20px 0 8px; border-radius: 4px; font-size: 14px;\"><strong>Why order compounds from MedsBase:<\/strong> Lyophilized HPLC \u226599% peptides &amp; compounds \u00b7 COA available on request \u00b7 Discreet protective packaging \u00b7 Worldwide courier \u00b7 <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\">\u518d\u767a\u9001\u4fdd\u8a3c<\/a> \u5168\u3066\u306e\u3054\u6ce8\u6587\u306b \u00b7 1,400\u4ef6\u4ee5\u4e0a\u306e\u78ba\u8a8d\u6e08\u307f <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Small-Molecule Companion Compounds<\/h2>\n<ul>\n<li><a href=\"\/ja\/l-carnitine\/\"><strong>L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/strong><\/a> \u2014 Mitochondrial fatty-acid shuttle \u2014 closest small-molecule companion analogue<\/li>\n<li><a href=\"\/ja\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Oxidised dinucleotide coenzyme \u2014 direct NAD-pool supplementation studies<\/li>\n<li><a href=\"\/ja\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2014 NNMT\u963b\u5bb3\u5264 \u2014 B12\uff0f\u30e1\u30c1\u30aa\u30cb\u30f3\u56de\u8def\u3092NAD\u8ef8\u30e1\u30c1\u30eb\u5316\u306b\u7d50\u3073\u3064\u3051\u308b<\/li>\n<li><a href=\"\/ja\/aicar-acadesine\/\"><strong>AICAR<\/strong><\/a> \u2014 Canonical small-molecule AMPK activator \u2014 companion metabolic support compound<\/li>\n<li><a href=\"\/ja\/mots-c\/\"><strong>MOTS-c<\/strong><\/a> \u2014 Mitochondrial-derived metabolic peptide \u2014 alternative-mechanism cofactor studies<\/li>\n<li><a href=\"\/ja\/bac-water\/\"><strong>BAC Water\uff08\u9759\u83cc\u6c34\uff09<\/strong><\/a> \u2014 \u5168\u3066\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306e\u518d\u6eb6\u89e3\u306b\u5fc5\u8981 \u2014 \u7121\u83cc\u30010.9%\u30d9\u30f3\u30b8\u30eb\u30a2\u30eb\u30b3\u30fc\u30eb\u4fdd\u5b58\u5e0c\u91c8\u6db2<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u30b3\u30d0\u30eb\u30c8\u4e2d\u5fc3\u306e\u30b3\u30ea\u30ce\u30a4\u30c9\u88dc\u9175\u7d20 \u2014 \u30d3\u30bf\u30df\u30f3B12\u30d5\u30a1\u30df\u30ea\u30fc\uff08CAS 68-19-9\uff09<br \/>\n\u2705 \u4e8b\u524d\u8abf\u88fd\u6e08\u307f\u306e\u7121\u83cc\u6c34\u6eb6\u6db2\uff08\u518d\u69cb\u6210\u4e0d\u8981\uff09<br \/>\n\u2705 1 mg\/mL \u00d7 10 mL multi-dose vial (10 mg total cyanocobalamin)<br \/>\n\u2705 \u7d30\u80de\u5185\u30e1\u30c1\u30aa\u30cb\u30f3\u5408\u6210\u9175\u7d20\uff0b\u30e1\u30c1\u30eb\u30de\u30ed\u30cb\u30ebCoA\u30e0\u30bf\u30fc\u30bc\u88dc\u56e0\u5b50<br \/>\n\u2705 Small-molecule companion compound (MW 1355.37, USP-grade)<\/p>\n<p><strong>\u30d3\u30bf\u30df\u30f3B12\uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff09\u6ce8\u5c04\u6db2<\/strong> 1 mg\/mL \u00d7 10 mL\u306e\u7121\u83cc\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\u6eb6\u6db2\u3092\u542b\u307f\u307e\u3059\u3002<\/p>","protected":false},"featured_media":71536,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6511,6510,6512,6513,6515,6514,3862],"class_list":["post-71466","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-cobalamin","product_tag-cyanocobalamin","product_tag-methionine-synthase-cofactor","product_tag-methylation-research","product_tag-research-companion","product_tag-small-molecule-research-compound","product_tag-vitamin-b12","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/71466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=71466"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/71536"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=71466"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=71466"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=71466"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=71466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}